Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Point and Figure Charting -- Ignore unavailable to you. Want to Upgrade?

To: wizzards wine who wrote (4162)	6/26/1998 7:26:00 PM
From: Judy	Read Replies (2) \| Respond to of 34817

Thanks, Preston P&F configuration as I expected. Now some thoughts for the thread beyond P&F ... Do you know that IMNX just got accepted for priority review by the FDA for their Phase III clinical trials for Enbrel, the most effective against RA with minimal side effects? Do you know how debilitating RA is .. and how many people worldwide are praying for some longer-term alleviation? Do you know the market potential once the FDA gives approval and the probability of this occurring on the first submittal? As most long-time readers know, I don't hold volatile, thin-float stocks just for the heck of it. PS: What is "RA"? Search Yahoo for IMNX and do some research.